Most cited papers in Geriatrics and Gerontology
What are the most cited papers in Geriatrics and Gerontology?
The most cited paper in Geriatrics and Gerontology is "Frailty in Older Adults: Evidence for a Phenotype" (Linda P. Fried, Catherine M. Tangen, Jeremy D Walston et al., 2001), with 25,162 citations. Next come "The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (19,132) and "Prediction of Creatinine Clearance from Serum Creatinine" (15,456).
Showing 50 of 98 papers. Every paper with more than 2,086 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Frailty in Older Adults: Evidence for a Phenotype Linda P. Fried, Catherine M. Tangen, Jeremy D Walston et al. · The Journals of Gerontology Series A | Mar 2001 | 25,162 |
| 2 | The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al. · Alzheimer s & Dementia | 22 Apr 2011 | 19,132 |
| 3 | Prediction of Creatinine Clearance from Serum Creatinine Donald W. Cockcroft, Henry Gault · The Nephron journals/Nephron journals | 28 Nov 2008 | 15,456 |
| 4 | Sarcopenia: revised European consensus on definition and diagnosis Alfonso José Cruz-Jentoft et al. · Age and Ageing | 24 Sep 2018 | 14,151 |
| 5 | A method for estimating the probability of adverse drug reactions C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics | Aug 1981 | 11,879 |
| 6 | Sarcopenia: European consensus on definition and diagnosis Alfonso José Cruz-Jentoft, Jean‐Pierre Baeyens, Jürgen Martin Bauer et al. · Age and Ageing | 13 Apr 2010 | 11,720 |
| 7 | Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Christopher J L Murray et al. · The Lancet | Oct 2020 | 9,961 |
| 8 | A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission Jack M. Guralnik, E. M. Simonsick, Luigi Ferrucci et al. · Journal of Gerontology | Mar 1994 | 9,940 |
| 9 | Frailty in elderly people Andrew Paul Clegg, John B. Young, Steve Iliffe et al. · The Lancet | 7 Feb 2013 | 9,683 |
| 10 | A global clinical measure of fitness and frailty in elderly people Kenneth J. Rockwood · Canadian Medical Association Journal | 29 Aug 2005 | 9,214 |
| 11 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Theo Vos et al. · The Lancet | Dec 2012 | 8,461 |
| 12 | Adherence to Medication Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine | 3 Aug 2005 | 8,018 |
| 13 | Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment Liang‐Kung Chen et al. · Journal of the American Medical Directors Association | 4 Feb 2020 | 7,159 |
| 14 | Dose translation from animal to human studies revisited Shannon Reagan‐Shaw, Minakshi Nihal, Nihal Ahmad · The FASEB Journal | 17 Oct 2007 | 6,526 |
| 15 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 Christina Fitzmaurice et al. · JAMA Oncology | 5 Dec 2016 | 6,333 |
| 16 | Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia Jeffrey Alan Lieberman, T. Scott Stroup, Joseph P. McEvoy et al. · New England Journal of Medicine | 19 Sep 2005 | 5,930 |
| 17 | EuroQol: the current state of play Richard G. Brooks · Health Policy | Jul 1996 | 5,926 |
| 18 | Rehospitalizations among Patients in the Medicare Fee-for-Service Program Stephen F. Jencks, Mark V. Williams, Eric A. Coleman · New England Journal of Medicine | Apr 2009 | 5,226 |
| 19 | Incidence of Adverse Drug Reactions in Hospitalized Patients Jason Lazarou, Bruce H. Pomeranz, Paul Corey · JAMA | 15 Apr 1998 | 4,842 |
| 20 | Gait Speed and Survival in Older Adults Stephanie A. Studenski · JAMA | 4 Jan 2011 | 4,585 |
| 21 | SF-36 Health Survey Update John E. Ware · Spine | Dec 2000 | 4,515 |
| 22 | Resveratrol improves health and survival of mice on a high-calorie diet Joseph A. Baur et al. · Nature | Nov 2006 | 4,279 |
| 23 | Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia Liang‐Kung Chen et al. · Journal of the American Medical Directors Association | 24 Jan 2014 | 4,202 |
| 24 | Frailty Consensus: A Call to Action John Edward Morley, Bruno J. Vellas, Gabor Abellán van Kan et al. · Journal of the American Medical Directors Association | Jun 2013 | 4,166 |
| 25 | Lower-Extremity Function in Persons over the Age of 70 Years as a Predictor of Subsequent Disability Jack M. Guralnik, Luigi Ferrucci, Eleanor Marie Simonsick et al. · New England Journal of Medicine | 2 Mar 1995 | 4,156 |
| 26 | Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care Linda P. Fried, Luigi Ferrucci, Jonathan D. Darer et al. · The Journals of Gerontology Series A | Mar 2004 | 4,107 |
| 27 | Epidemiology of Sarcopenia among the Elderly in New Mexico Richard Baumgartner, Kathleen M. Koehler, Dympna Gallagher et al. · American Journal of Epidemiology | 15 Apr 1998 | 4,054 |
| 28 | Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α Marie Lagouge, Carmen Argmann, Zachary Gerhart‐Hines et al. · Cell | 17 Nov 2006 | 4,041 |
| 29 | SOME QUANTITATIVE USES OF DRUG ANTAGONISTS O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy | Mar 1959 | 3,967 |
| 30 | Therapeutic potential of resveratrol: the in vivo evidence Joseph A. Baur, David A. Sinclair · Nature Reviews Drug Discovery | 26 May 2006 | 3,951 |
| 31 | Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Konrad T. Howitz, Kevin J. Bitterman, Haim Yosef Cohen et al. · Nature | 24 Aug 2003 | 3,797 |
| 32 | Development and psychometric evaluation of the Resilience Scale. Gail M. Wagnild, Heather M. Young · PubMed | 1993 | 3,774 |
| 33 | Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty Luigi Ferrucci, Elisa Fabbri · Nature Reviews Cardiology | 31 Jul 2018 | 3,731 |
| 34 | A standard procedure for creating a frailty index Samuel D. Searle, Arnold Mitnitski, Evelyne A. Gahbauer et al. · BMC Geriatrics | 30 Sep 2008 | 3,684 |
| 35 | Self-eating and self-killing: crosstalk between autophagy and apoptosis Maria Chiara Maiuri, Einat Zalckvar, Adi Kimchi et al. · Nature Reviews Molecular Cell Biology | 23 Aug 2007 | 3,659 |
| 36 | Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission Gill Livingston et al. · The Lancet | 31 Jul 2024 | 3,635 |
| 37 | Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Shin‐ichiro Imai, Christopher M. Armstrong, Matt R. Kaeberlein et al. · Nature | Feb 2000 | 3,531 |
| 38 | The APACHE III Prognostic System William A. Knaus, Douglas P. Wagner, Elizabeth A. Draper et al. · CHEST Journal | Dec 1991 | 3,502 |
| 39 | COSMIN guideline for systematic reviews of patient-reported outcome measures C.A.C. Prinsen, Lidwine Brigitta Mokkink, L.M. Bouter et al. · Quality of Life Research | 12 Feb 2018 | 3,453 |
| 40 | Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Catherine Owens Johnson et al. · The Lancet Neurology | 11 Mar 2019 | 3,411 |
| 41 | What is polypharmacy? A systematic review of definitions Nashwa Masnoon, Sepehr Shakib, Lisa M. Kalisch Ellett et al. · BMC Geriatrics | 10 Oct 2017 | 3,401 |
| 42 | Frailty: implications for clinical practice and public health Emiel O. Hoogendijk, Jonathan Afilalo, Kristine E. Ensrud et al. · The Lancet | Oct 2019 | 3,395 |
| 43 | The World report on ageing and health: a policy framework for healthy ageing John Beard, Alana Officer, Islène Araujo de Carvalho et al. · The Lancet | 3 Nov 2015 | 3,333 |
| 44 | Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia Roger A. Fielding et al. · Journal of the American Medical Directors Association | 5 Mar 2011 | 3,319 |
| 45 | AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Carles Cantó, Zachary Gerhart‐Hines, Jérôme N. Feige et al. · Nature | 4 Mar 2009 | 3,299 |
| 46 | Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase Anne Sophie Brunet, Lora B. Sweeney, James Fitzhugh Sturgill et al. · Science | 23 Feb 2004 | 3,267 |
| 47 | Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ | Jul 2004 | 3,262 |
| 48 | Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells Ying Yang, Shuping Li, Qiao Yang et al. · Cellular Physiology and Biochemistry | 2014 | 3,256 |
| 49 | American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel · Journal of the American Geriatrics Society | 29 Jan 2019 | 3,220 |
| 50 | Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability Ian Janssen, Steven B. Heymsfield, Robert R. Ross · Journal of the American Geriatrics Society | May 2002 | 3,175 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.